In view of the steady market growth of GLP-1RA drugs and prospects of potential expansion to hugely profitable and self-selling indications such as weight management or Parkinsons disease [38], research is urgently needed to clarify the relationship between the use of GLP-1RA and mental health, as well as to identify individuals at a higher risk of suicidal ideation and self-injury
[3] That framing is instructive: GHK-Cu may be most useful when tissue repair demand is high (post-surgery, injury, visible aging), which is also often the context in which sermorelin is prescribed for adults
As their use expands, patients and clinicians naturally question potential adverse effects, including whether these medications increase the risk of blood clots
Gastrointestinal Symptoms : nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, heartburn, and impaired motility Secretomotor Symptoms : difficulty sweating, tearing, and other fluid production (dry eyes, dry mouth, difficulty swallowing, dry skin)
K.McLeanB
PubMed laboratory research record [PMID: 28419998] PubMed record related to this compound for laboratory literature review